| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 67028 |
Intravitreal injection of a pharmacologic agent |
15,041 |
11,932 |
$349K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
6,235 |
4,921 |
$176K |
| J9035 |
Injection, bevacizumab, 10 mg |
11,424 |
9,317 |
$170K |
| J2778 |
Injection, ranibizumab, 0.1 mg |
445 |
433 |
$86K |
| 92134 |
|
15,852 |
13,003 |
$85K |
| 92235 |
|
3,741 |
3,021 |
$68K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,617 |
4,316 |
$61K |
| 92250 |
|
4,976 |
3,936 |
$42K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
2,634 |
2,417 |
$30K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
606 |
585 |
$24K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
359 |
285 |
$16K |
| 4040F |
|
17,885 |
14,425 |
$9K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
384 |
369 |
$6K |
| G9744 |
Patient not eligible due to active diagnosis of hypertension |
15,067 |
12,446 |
$6K |
| 1036F |
|
16,905 |
13,941 |
$3K |
| J7999 |
Compounded drug, not otherwise classified |
2,950 |
1,435 |
$3K |
| 92226 |
|
796 |
558 |
$3K |
| 92225 |
|
428 |
289 |
$3K |
| G8482 |
Influenza immunization administered or previously received |
10,209 |
8,579 |
$2K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
56 |
48 |
$2K |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
15,591 |
12,918 |
$1K |
| G8397 |
Dilated macular or fundus exam performed, including documentation of the presence or absence of macular edema and level of severity of retinopathy |
10,277 |
8,453 |
$378.27 |
| G8785 |
Blood pressure reading not documented, reason not given |
4,124 |
3,385 |
$298.56 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
17,946 |
14,959 |
$163.99 |
| 5010F |
|
10,539 |
8,549 |
$153.90 |
| G9902 |
Patient screened for tobacco use and identified as a tobacco user |
2,340 |
1,787 |
$69.73 |
| G9906 |
Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) |
1,742 |
1,286 |
$69.72 |
| 4004F |
|
1,390 |
977 |
$67.39 |
| 2022F |
|
10,826 |
8,737 |
$15.74 |
| 2026F |
|
10,778 |
8,708 |
$0.00 |
| 2024F |
|
10,814 |
8,722 |
$0.00 |
| G9974 |
Dilated macular exam performed, including documentation of the presence or absence of macular thickening or geographic atrophy or hemorrhage and the level of macular degeneration severity |
3,989 |
3,415 |
$0.00 |
| 0517F |
|
524 |
430 |
$0.00 |
| 2027F |
|
83 |
75 |
$0.00 |
| 4177F |
|
4,171 |
3,541 |
$0.00 |
| G8428 |
Current list of medications not documented as obtained, updated, or reviewed by the eligible clinician, reason not given |
1,529 |
1,223 |
$0.00 |